micro News and Research

RSS

EKF Diagnostics to introduce upgraded POC analyzer and new sTNFr1 test kit at Medica 2013

EKF, announces it will be premiering two novel diagnostic tests at Medica 2013, 20th to 23rd November, Düsseldorf, Germany.

From EKF Diagnostics 8 Nov 2013

IUSL awarded patent for method for changing perception of skin tone

How someone perceives color is determined by how the item they are looking at scatters and emits light. In August, three City College of New York physicists affiliated with the Institute for Ultrafast Spectroscopy and Lasers (IUSL) were awarded a patent for a method for changing perception of skin tone by applying quantum and optical principles to cosmetic preparations.

6 Nov 2013

Valeant Pharmaceuticals' total revenues increase 74% to $1.54B in Q3 2013

Valeant Pharmaceuticals International, Inc. announces third quarter financial results for 2013. "Despite an unexpected early launch of a generic Retin-A Micro, significant headwinds this quarter from foreign exchange movements, and the demands of a major integration, we managed to beat expectations and position Valeant for a terrific fourth quarter and a strong 2014," stated J. Michael Pearson, chairman and chief executive officer.

31 Oct 2013

Researchers receive grant to develop new device that identifies healthy sperm cells for IVF

The World Health Organization estimates more than 70 million couples worldwide are unable to conceive each year, with close to a third of those cases attributable solely to issues with male fertility-including low sperm count and low sperm motility (a limited ability to swim).

31 Oct 2013

Eliza's Star multi-modal programs address gaps in healthcare

Eliza Corporation ("Eliza"), the pioneer and recognized leader in Health Engagement Management, today announced "Star 2014", a proactive member communication solutions suite that addresses key areas of the Centers for Medicare & Medicaid Services (CMS) Star programs.

30 Oct 2013

Researchers overcome obstacle to using viruses to deliver therapeutic genes

Scientists in The Research Institute at Nationwide Children's Hospital have found a way to overcome one of the biggest obstacles to using viruses to deliver therapeutic genes: how to keep the immune system from neutralizing the virus before it can deliver its genetic payload. In a study published recently in Molecular Therapy, researchers found that giving subjects a treatment to temporarily rid the body of antibodies provides the virus safe passage to targeted cells, allowing it to release a corrective or replacement gene to treat disease.

30 Oct 2013

Sanovas receives patent for Multi-Balloon Catheter for Extravasated Drug Delivery

Sanovas Inc., (www.sanovas.com) a life science technology company focused on developing and commercializing next generation micro-invasive diagnostics, devices and drug delivery technologies, announced today that the United States Patent and Trademark Office issued patent # 8,540,667 for the company's Multi-Balloon Catheter for Extravasated Drug Delivery.

29 Oct 2013

One in six fatal traffic accidents results from drowsy driving, show reports

Many of us make light of that relatively short drive home. But getting behind the wheel when you're sleepy can cost lives and lead to imprisonment and a hefty fine.

29 Oct 2013

Psychosis prediction model could facilitate early intervention

A integrated model has shown “outstanding” ability to predict the transition to psychosis in clinically high-risk patients, report investigators in Schizophrenia Bulletin.

25 Oct 2013

"One-two punch" disables tumors' defenses

An aggressive form of breast cancer known as "triple negative" is very difficult to treat: Chemotherapy can shrink such tumors for a while, but in many patients they grow back and gain resistance to the original drugs.

25 Oct 2013

Researchers develop robots for bridge inspection, mine rescue, aid for blind

Robotic rotorcraft for inspecting bridges and other infrastructure, tools for minimally invasive surgery that guide surgeons by creating 3D maps of internal organs and assistive robots for blind travelers are among seven new Carnegie Mellon University research projects sponsored through the National Robotics Initiative.

25 Oct 2013

Study could enhance process of reprogramming adult cells into embryonic-like stem cells

Bioengineers at the University of California, Berkeley, have shown that physical cues can replace certain chemicals when nudging mature cells back to a pluripotent stage, capable of becoming any cell type in the body.

23 Oct 2013

U of T researchers develop method to screen human stem cells

University of Toronto researchers have developed a method that can rapidly screen human stem cells and better control what they will turn into. The technology could have potential use in regenerative medicine and drug development. Findings are published in this week's issue of the journal Nature Methods.

23 Oct 2013

COPD investigational treatments: an interview with Dr. Tunde Otulana, Senior Vice President, Clinical Development and Medical Affairs, Boehringer Ingelheim Pharmaceuticals, Inc.

Olodaterol is a long-acting beta2-agonist (LABA) bronchodilator delivered via the Respimat® inhaler. It is being investigated as a once daily maintenance bronchodilator treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema.

21 Oct 2013

European Commission approves updated label of Prevenar 13 for high risk pneumococcal disease

Pfizer Inc. (NYSE:PFE) announced today that the European Commission approved updates to the Summary of Product Characteristics (SmPC) for the company's pneumococcal conjugate vaccine Prevenar 13* (pneumococcal polysaccharide conjugate vaccine [13-valent, adsorbed]), regarding its use in certain populations at high risk of pneumococcal disease.

18 Oct 2013

Air pollution hampers fetal growth

Exposure to common air pollutants and traffic during pregnancy significantly increases the risk of restricted fetal growth, even at levels well below those stipulated in current European Union (EU) air-quality directives, according to one of the largest studies of its kind, published in The Lancet Respiratory Medicine.

17 Oct 2013

House dust mite allergy treatment: an interview with Steve Harris, CEO & Co-founder of Circassia

House dust mite allergy is a surprisingly prevalent problem. Something like 27% of the U.S. population and 20% of the European population are what’s called skin-prick test positive for house dust mites, which is a test for sensitivity to allergens to find out if a person is likely to get that allergy.

15 Oct 2013

Crown Bioscience enters into collaboration with Xstrahl for radiation biology research

Crown Bioscience, Inc., a leading global drug discovery and development service company, today announces that it has entered into a collaboration with Xstrahl Ltd, a leading designer and manufacturer of X-Ray solutions for radiation biology research.

From Xstrahl 15 Oct 2013

Drugs often fail to bring acromegaly under control in routine clinical practice

Over a quarter of UK patients treated for growth hormone-producing tumours do not achieve 'safe' growth hormone levels, according to a 30 year UK multi-centre study of clinical management of the rare disease acromegaly. The findings by the Society for Endocrinology UK Acromegaly Register, published in the November issue of Clinical Endocrinology, show that drugs to control acromegaly often fail to bring the disease completely under control in routine clinical practice.

10 Oct 2013

People without insurance seek new options from insurance marketplaces

For consumers who are seeking insurance through the new law, the marketplace's technical problems have been frustrating, but many remain eager.

4 Oct 2013

micro News and Research

EKF Diagnostics to introduce upgraded POC analyzer and new sTNFr1 test kit at Medica 2013

IUSL awarded patent for method for changing perception of skin tone

Valeant Pharmaceuticals' total revenues increase 74% to $1.54B in Q3 2013

Researchers receive grant to develop new device that identifies healthy sperm cells for IVF

Eliza's Star multi-modal programs address gaps in healthcare

Researchers overcome obstacle to using viruses to deliver therapeutic genes

Sanovas receives patent for Multi-Balloon Catheter for Extravasated Drug Delivery

One in six fatal traffic accidents results from drowsy driving, show reports

Psychosis prediction model could facilitate early intervention

"One-two punch" disables tumors' defenses

Researchers develop robots for bridge inspection, mine rescue, aid for blind

Study could enhance process of reprogramming adult cells into embryonic-like stem cells

U of T researchers develop method to screen human stem cells

COPD investigational treatments: an interview with Dr. Tunde Otulana, Senior Vice President, Clinical Development and Medical Affairs, Boehringer Ingelheim Pharmaceuticals, Inc.

European Commission approves updated label of Prevenar 13 for high risk pneumococcal disease

Air pollution hampers fetal growth

House dust mite allergy treatment: an interview with Steve Harris, CEO & Co-founder of Circassia

Crown Bioscience enters into collaboration with Xstrahl for radiation biology research

Drugs often fail to bring acromegaly under control in routine clinical practice

People without insurance seek new options from insurance marketplaces

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News